Awasthi M, Golding H, Khurana S. SARS-CoV-2 hyperimmune intravenous human immunoglobulins neutralizes Omicron subvariants BA.1, BA.2, BA.2.12.1, BA.3 and BA.4/BA.5 for treatment of COVID-19. Clin Infect Dis 2022 Aug 4. pii: 6655744. doi: 10.1093.
PMID: 35925647